SUVEN

HealthcareDrug Manufacturers - Specialty & GenericMid Cap
Suven Life Sciences Limited

Suven Life Sciences Limited is a clinical-stage biopharmaceutical company operating in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic. It focuses on t...

हिन्दी में

Suven Life Sciences Limited हेल्थकेयर सेक्टर की एक क्लिनिकल-स्टेज बायोफार्मास्युटिकल कंपनी है, जो विशेष रूप से ड्रग मैन्युफैक्चरर्स - स्पेशलिटी एंड जेनेरिक उप-सेक्टर में काम करती ह...

₹282.75-2.13%1D
Previous trading day close · Data updates after market close
1W: -7.7%
1M: -20.9%
6M: +48.5%
1Y: +38.0%
36/100
PoorResearch Score
Market Cap
₹7.1K Cr
Mid Cap
P/E Ratio
-31.30
Negative earnings
P/B Ratio
78.63
Premium
ROE
-84.6%
Weak
ROCE
-247.3%
Average
Debt / Equity
0.00
Low debt
Div. Yield
N/A
EV/EBITDA
N/A
52W Low: ₹124.11Current: ₹282.7552W High: ₹403.35
At 57% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
39/100
Growth
Revenue, EPS, profit growth
24/100
Valuation
PE, PB, EV/EBITDA vs sector
32/100
Risk
Debt levels, volatility, coverage
48/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
-31.30(Negative earnings)
Forward P/E
N/A
P/B Ratio
78.63(Premium)
P/S Ratio
411.05(Expensive)
EV/EBITDA
N/A
Dividend Yield
N/A
5Y CAGR
31.9%(High growth)
Revenue Growth
19.8%(Moderate)
Profitability
ROE
-84.6%(Average)
ROCE
-247.3%(Average)
ROA
-76.5%(Average)
Net Margin
-1313.5%(Low)
EBITDA Margin
-1286.0%
Financial Health
Debt to Equity
0.00(Low debt)
Current Ratio
3.21(Healthy)
Quick Ratio
3.20(Good)
Interest Coverage
-1726.19x(Low)
Technical Indicators
Based on previous trading day close
RSI (14)
15(Oversold)
RSI Exp (14)
9(Oversold)
MACD
-14.896(Bearish)
MACD Signal
-9.727
BB Position
-2%(Lower band)
BB Width
25.75%(High volatility)
ADX (14)
53.2(Very Strong)
Williams %R
-96.8(Oversold)
MFI (14)
17(Oversold)
CCI (20)
-176(Oversold)
Stoch %K
3(Oversold)
ATR (14)
12.35(Avg True Range)
OBV (M)
103.3(Positive)
1W OBV Chg
-0.8%(Decreasing)
Rel Volume
0.80x(Normal)
Volatility
58.8%(High)
Max DD 1Y
-57.3%(High loss)
EMA 200
269.9
EMA 50
328.4
SMA 200
241.2
vs SMA 50
-16.7%(Below SMA50)
vs SMA 200
17.3%(Above SMA200)
Volume
5.83L
Avg Vol 3M
7.3L
Shareholding Pattern
Promoter
70.2%
High confidence
FII
0.9%
DII / MF
4.6%
Share SUVEN
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.